Status:
UNKNOWN
Biomarkers for Acute Graft-versus-host Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Acute GVH Disease
Eligibility:
All Genders
18-75 years
Brief Summary
Validation of already described biomarkers on acute GVHD prediction and severity Fecal calprotectin and alpha 1 anti-trypsin, plasmatic RER3a, IL-8, Elafin, TNFaR1, IL-2R alpha, HGF
Detailed Description
Description of the project: The main objective of this prospective biological single center study (non interventional) is to identify non invasive biomarkers able to diagnose acute GVHD and/or predict...
Eligibility Criteria
Inclusion
- adult patients receiving an allogeneic transplant
- informed consent signed
Exclusion
- patient refusal
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
315 Patients enrolled
Trial Details
Trial ID
NCT02254798
Start Date
January 1 2014
End Date
December 1 2017
Last Update
October 2 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-Louis
Paris, France
2
Hôpital Saint-Louis
Paris, France